本页面由Tiger Trade Technology Pte. Ltd.提供服务

Karyopharm Therapeutics Inc.

1.86
-0.1000-5.10%
盘后1.870.0100+0.54%19:35 EDT
成交量:84.58万
成交额:158.62万
市值:4,215.31万
市盈率:-0.14
高:1.96
开:1.95
低:1.83
收:1.96
52周最高:10.99
52周最低:1.79
股本:2,266.29万
流通股本:1,706.56万
量比:0.83
换手率:4.96%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
净资产收益率:-891.05%
总资产收益率:-47.61%
市净率:-0.13
市盈率(LYR):-0.10

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/06/05

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/13

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

SEC问询函

Form CORRESP - Correspondence